GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (OTCPK:DOSEF) » Definitions » Capital Expenditure

DOSEF (Doseology Sciences) Capital Expenditure : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Doseology Sciences Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Doseology Sciences's cash flow for capital expenditures for the three months ended in Dec. 2024 was $0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.


Doseology Sciences Capital Expenditure Historical Data

The historical data trend for Doseology Sciences's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doseology Sciences Capital Expenditure Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Capital Expenditure
- -0.14 -0.01 - -

Doseology Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Doseology Sciences Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doseology Sciences Business Description

Traded in Other Exchanges
Address
9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.

Doseology Sciences Headlines

From GuruFocus

Doseology Provides Corporate Update

By PRNewswire PRNewswire 01-23-2023

Doseology Uplists to OTCQB Market in USA

By PRNewswire PRNewswire 07-06-2022

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-11-2022

Doseology Announces CEO Transition

By PRNewswire PRNewswire 03-31-2023

Doseology Welcomes New CFO

By PRNewswire PRNewswire 03-03-2023

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-21-2022

Doseology Opens to American Investors

By PRNewswire PRNewswire 07-11-2022

Doseology Announces New Director and Corporate Secretary

By PRNewswire PRNewswire 05-05-2023

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-01-2022